Your browser doesn't support javascript.
loading
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts.
Li, Kuanrong; Anderson, Garnet; Viallon, Vivian; Arveux, Patrick; Kvaskoff, Marina; Fournier, Agnès; Krogh, Vittorio; Tumino, Rosario; Sánchez, Maria-Jose; Ardanaz, Eva; Chirlaque, María-Dolores; Agudo, Antonio; Muller, David C; Smith, Todd; Tzoulaki, Ioanna; Key, Timothy J; Bueno-de-Mesquita, Bas; Trichopoulou, Antonia; Bamia, Christina; Orfanos, Philippos; Kaaks, Rudolf; Hüsing, Anika; Fortner, Renée T; Zeleniuch-Jacquotte, Anne; Sund, Malin; Dahm, Christina C; Overvad, Kim; Aune, Dagfinn; Weiderpass, Elisabete; Romieu, Isabelle; Riboli, Elio; Gunter, Marc J; Dossus, Laure; Prentice, Ross; Ferrari, Pietro.
Afiliação
  • Li K; Nutritional Methodology and Biostatistics Group, Nutrition and Metabolism Section, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
  • Anderson G; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, USA.
  • Viallon V; Nutritional Methodology and Biostatistics Group, Nutrition and Metabolism Section, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372, Lyon Cedex 08, France.
  • Arveux P; Breast and Gynaecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, Dijon, France.
  • Kvaskoff M; EA 4184, Medical School, University of Burgundy, Dijon, France.
  • Fournier A; CESP, INSERM U1018, Univ. Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
  • Krogh V; Gustave Roussy, Villejuif, France.
  • Tumino R; CESP, INSERM U1018, Univ. Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
  • Sánchez MJ; Gustave Roussy, Villejuif, France.
  • Ardanaz E; CESP, INSERM U1018, Univ. Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
  • Chirlaque MD; Gustave Roussy, Villejuif, France.
  • Agudo A; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Muller DC; Cancer Registry and Histopathology Department, "Civic-M. P.Arezzo" Hospital, ASP, Ragusa, Italy.
  • Smith T; Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs. GRANADA, Hospitales Universitarios de Granada/ Universidad de Granada, Granada, Spain.
  • Tzoulaki I; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Key TJ; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Bueno-de-Mesquita B; Navarra Public Health Institute, Pamplona, Spain.
  • Trichopoulou A; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Bamia C; CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
  • Orfanos P; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Kaaks R; Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain.
  • Hüsing A; Unit of Nutrition and Cancer. Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.
  • Fortner RT; Department of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Zeleniuch-Jacquotte A; Department of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Sund M; Department of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Dahm CC; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Overvad K; Department of Epidemiology & Biostatistics, School of Public Health, Imperial College London, London, UK.
  • Aune D; Department for Determinants of Chronic Diseases, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
  • Weiderpass E; Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands.
  • Romieu I; Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
  • Riboli E; Hellenic Health Foundation, Athens, Greece.
  • Gunter MJ; WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Dossus L; Hellenic Health Foundation, Athens, Greece.
  • Prentice R; WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Ferrari P; Hellenic Health Foundation, Athens, Greece.
Breast Cancer Res ; 20(1): 147, 2018 12 03.
Article em En | MEDLINE | ID: mdl-30509329
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Modelos Biológicos / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Modelos Biológicos / Antineoplásicos Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article